GFRAL and obesity due to melanocortin 4 receptor deficiency: Our results indicated that artesunate normalises body weight both prophylactically and therapeutically, while reversing metabolic abnormalities commonly associated with obesity in a GDF15/GFRAL axis-dependent manner.